*Benchalak Maneeton1, Prapinpatch Maneeton2, Yanisa Winichaikul3, Suttipong Kawilapat1, Nongluck Kienngam4, Narong Maneeton1 (1. Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand, 2. Chiang Mai University Demonstration School, Faculty of Education, Chiang Mai University, Chiang Mai 50200, Thailand, 3. Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand., 4. Department of Education Psychology and Guidance Program, Faculty of Education Chiang Mai University, Chiang Mai 50200, Thailand)
セッション情報
[CINP2024] Poster Session
CINP2024 » Poster Session
Autism
2024年5月25日(土) 16:50 〜 17:50 CINP Poster Session Hall (Lobby Gallery)
*Agata Dzwonek1, Martin Campbell1 (1. University of Ottawa)
*Tomoyasu Wakuda1, Seico Benner1,2, Yukari Uemura3, Masaki Kojima4, Yosuke Kameno1,5, Hitoshi Kuwabara1,5, Hidenori Yamasue1,5, +32 co-authors6 (1. Department of Psychiatry, Hamamatsu University School of Medicine, Shizuoka, Japan, 2. Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Ibaraki, Japan, 3. Biostatistics Section, Department of Data Science, Center for Clinical Science, National Center for Global Health and Medicine, Tokyo, Japan, 4. Department of Child Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 5. Department of Child Development, United Graduate School of Child Development at Hamamatsu, Shizuoka, Japan, 6. University Hospitals in Japan)
*Yi-Chun Liu1,2,3, Yin-To Liao, Vincent chin-hong Chen, Yi-Lung Chen (1. Department of Healthcare Administration, Asia University, Taichung, Taiwan, 2. Department of psychiatry, Changhua Christian Hospital, Changhua, Taiwan, 3. Department of psychiatry, Changhua Christian Children's Hospital, Changhua, Taiwan)
*Hanyong Jung1, Jeewon Lee1 (1. SOONCHUNHYANG UNIVERSITY BUCHEON HOSPITAL)
*Kohei Kitagawa1, Tomoya Takemoto1, Kaoru Seiriki1, Atsushi Kasai1,2, Hitoshi Hashimoto1,3,4,5,6, Takanobu Nakazawa7 (1. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 2. Systems Brain Science Project, Drug Innovation Center, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 3. United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Japan, 4. Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan, 5. Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan, 6. Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University, Osaka, Japan, 7. Department of Bioscience, Faculty of Bioscience, Tokyo University of Agriculture, Tokyo, Japan)
*Yoko Nawata1, Tsuyoshi Nishioku1, Taku Yamaguchi2 (1. Department of Pharmacology, Faculty of Pharmaceutical Science, Nagasaki International University, Nagasaki, Japan, 2. Department of Pharmacotherapeutics and Neuropsychopharmacology, Faculty of Pharmaceutical Science, Nagasaki International University, Nagasaki, Japan)
*Satomi Matsuoka1, Yuka Moriya1, Fuyuka Ito1, Mai Miyachi1, Takemi Fuwa2, Hitomi Kurahashi2, Toshitaka Nabeshima2,3, Akihiro Mouri2,3, Yoichi Hasegawa1 (1. Meijo University, 2. Fujita Health University Graduate School of Health Science, 3. Japanese Drug Organization of Appropriate Use and Research)
*Mao Suzuki1,2, Nobuhiro Nakai1, Noriko Osumi2, Toru Takumi1 (1. Kobe University School of Medicine, 2. Tohoku University Graduate School of Medicine)
*Yi-Ting Pan1, Chi-Chun Wu3, Ming-Chai Chu3, Chen-Jiun Yeh1, Dishary Sharmin4, James Cook4, Hui-Ching Lin3, Lih-Chu Chiou1,2 (1. Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan, 2. Graduate Institute of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan, 3. Department and Institute of Physiology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, 4. Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI, USA)
*Tetsuya Sasaki1, Sara Kamiya1, Kyoko Kishi1, Suguru Iwata1, Yosuke Takei1 (1. University of Tsukuba)
*Hiroko Kotajima1, Atsushi Sato1, Shinya Kasai2, Yoko Hagino1, Miho Tanaka3, Yukio Takamatsu4, Yoshimasa Nishito4, Shigeo Uchino5, Kazutaka Ikeda1 (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Japan, 2. Department of Biotechnology, Center for Advanced Assisted Reproductive Technologies, University of Yamanashi, Japan, 3. Department of Psychiatry, The University of Tokyo Hospital, Japan, 4. Center for Basic Technology Research, Tokyo Metropolitan Institute of Medical Science, Japan, 5. Department of Biosciences, School of Science and Engineering, Teikyo University, Japan)
*Shuntaro Matsushima1, Daiki Nasukawa1, Kota Yamada2, Haruka Hirakata1, Ryuto Tamura1, Saya Yatagai1, Kazuko Hayashi1, Yusuke Ujihara3, Koji Toda1 (1. Keio University , 2. The University of Tokyo, 3. University of Tennessee Health Science Center)
Chia-Wei Liou1,2, Sin-Jhong Cheng3, Tzu-Hsuan Yao1,2, Tzu-Ting Lai1,2, Yu-Hsuan Tsai1,2, *Wei-Li Wu1,2 (1. Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 2. Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, 3. Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan)
*Tobias Patrick Whelan1,2, Lucas G.S. Franca 1,3, Mihail Dimitrov 1, Naoise Mulcrone 1, Nicolaas A. Puts1,4, Eileen Daly 1, Declan G.M. Murphy1,4, Grainne M. McAlonan1,4 (1. Dept. of Forensic & Neurodevelopmental Sciences, King's College London, , 2. COMPASS Pathfinder Ltd. , 3. Dept. of Computer & Information Sciences, Northumbria University , 4. NIHR-Maudsley Biomedical Research Centre at Maudsley NHS Foundation Trust & King's College London )
Asim Ahmed1, Abdulrahman Abushaibah1, Kyle Mayr1, Veronica Rasheva1, MoonYoung Bae1, Patrick Whelan1, Kartikeya Murari1, *Ning Cheng1 (1. University of Calgary)
*Shotaro Kawano1, Toshihiko Kuriu2, Sayaka Katayama1, Manaka Otomo1, Daiki Miura1, Hotaka Fukushima1, Kazuhiro Takuma3, Fumihito Ono4, Hitoshi Hashimoto5,6,7,8,9,10, Ryota Hashimoto6, Takanobu Nakazawa1,6 (1. Department of Bioscience, Graduate School of Life Sciences, Tokyo University of Agriculture, Tokyo, Japan, 2. Osaka Medical and Pharmaceutical University, Research and Development Center, Osaka, Japan, 3. Department of Pharmacology, Graduate School of Dentistry, Osaka University, Osaka, Japan, 4. Department of Physiology, Division of Life Science, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan, 5. Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 6. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 7. United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Japan, 8. Division of Bioscience, Institute for Datability Science, Osaka University, Osaka, Japan, 9. Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan, 10. Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University, Osaka, Japan)